Effects of Semaglutide on Nicotine Intake

Clinical trial NCT05530577 · COMPLETED

Trial details

NCT number: NCT05530577
Sponsor: University of North Carolina, Chapel Hill
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Tobacco Use Disorder Nicotine Addiction

Start date: 2022-10-07
Primary completion: 2024-05-13
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.